Moody’s assigns Ba3 to Yestar

Moody's Investors Service said it assigned a Ba3 corporate family rating to Yestar International Holdings Co. Ltd.

The outlook is stable.

"Yestar's Ba3 rating reflects the company's strengthening positioning in the distribution of medical consumable products in China, its strong and sustainable partnership with leading global players, a risk-controlled M&A strategy, and prudent financial management," Moody's vice president and senior analyst Gloria Tsuen said in a news release.

"At the same time, the rating is constrained by the company's modest size with high supplier concentration, relatively short operating history in distributing in vitro diagnostic products (IVD), and high cash investment requirements as it continues to pursue growth."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.